TTL


Summary: TTL is a cytosolic enzyme involved in the posttranslational modification of alpha-tubulin (see MIM 602529). Alpha-tubulin within assembled microtubules is detyrosinated over time at the C terminus. After microtubule disassembly, TTL restores the tyrosine residues and consequently participates in a cycle of tubulin detyrosination and tyrosination (Erck et al., 2003 [PubMed 14571137]).[supplied by OMIM, Mar 2008].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

GO terms in TTL


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
BP IEA GO:0000226 microtubule cytoskeleton organization
BP IMP GO:0018166 C-terminal protein-tyrosinylation
BP IEA GO:0030516 regulation of axon extension
BP IMP GO:0045931 positive regulation of mitotic cell cycle
BP IMP GO:0090235 regulation of metaphase plate congression
CC IMP GO:0005623 cell
Showing 1 to 6 of 8 rows

Gene expression in normal tissue: TTL

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

undefined27Leukocyte transendothelial migration1Apoptosis regulation1One carbon pool by folate1Protein stability and degradation1Mitosis1DNA replication1p53 pathway1

Pathways in TTL


Loading, please wait...
Database
Pathway ID
Pathway Des.
reactome R-HSA-392499 Metabolism of proteins
reactome R-HSA-597592 Post-translational protein modification
reactome R-HSA-8955332 Carboxyterminal post-translational modifications of tubulin
Showing 1 to 3 of 3 rows

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD872 BRD7137 3
iGMDRD329 Merck60 3
iGMDRD300 Tozasertib 3
iGMDRD137 Indisulam 6
Showing 1 to 4 of 34 rows rows per page

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in TTL

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​